VECTIVBIO HLDG AG's ticker is VECT and the CUSIP is H9060V101. A total of 27 filers reported holding VECTIVBIO HLDG AG in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $21,587 | -1.8% | 2,536,617 | 0.0% | 1.42% | -3.3% |
| Q4 2022 | $21,980 | -99.9% | 2,536,617 | 0.0% | 1.47% | +38.3% |
| Q3 2022 | $15,220,000 | -0.8% | 2,536,617 | -10.7% | 1.06% | -8.3% |
| Q2 2022 | $15,338,000 | +56.7% | 2,840,389 | +36.7% | 1.16% | +54.3% |
| Q1 2022 | $9,790,000 | -10.1% | 2,078,485 | -6.2% | 0.75% | +16.2% |
| Q4 2021 | $10,884,000 | -36.7% | 2,216,763 | -0.4% | 0.65% | -7.4% |
| Q3 2021 | $17,197,000 | -32.6% | 2,226,128 | 0.0% | 0.70% | -19.4% |
| Q2 2021 | $25,531,000 | – | 2,226,128 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,084,310 | $14,527,000 | 6.18% |
| Novo Holdings A/S | 3,380,402 | $15,922,000 | 0.84% |
| Cormorant Asset Management, LP | 2,078,485 | $9,790,000 | 0.75% |
| Orbimed Advisors | 5,330,704 | $25,108,000 | 0.41% |
| Bpifrance SA | 2,806,217 | $13,217,000 | 0.37% |
| Eventide Asset Management | 2,339,044 | $10,994,000 | 0.17% |
| Tekla Capital Management LLC | 756,502 | $3,556,000 | 0.12% |
| Canaan Partners XI LLC | 37,051 | $175,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 393,365 | $1,849,000 | 0.02% |
| Citadel Advisors | 2,722,646 | $12,797,000 | 0.00% |